Why when Luke O' Neill gets so much airtime to advise the nation, could some of that time not be spent having him declare his interests? Strong ties to both GSK and Moderna. @laoneill111 @PatKennyNT @Niall_Boylan @rte @DefundRte #Ireland #covidireland @griptmedia #COVID19 https://twitter.com/fcraul2/status/1283765329374539776
Long Version:
He worked with GSK, then co founded "Sitryx" which received $30,000,000 initial investment from GSK and others
http://universitytimes.ie/2018/10/company-co-founded-by-luke-oneill-raises-30m-in-first-funding-round/... Investors: http://sitryx.com/investors/
He worked with GSK, then co founded "Sitryx" which received $30,000,000 initial investment from GSK and others
http://universitytimes.ie/2018/10/company-co-founded-by-luke-oneill-raises-30m-in-first-funding-round/... Investors: http://sitryx.com/investors/
It's very interesting that Sitryx made an $880,000,000 deal with "Eli Lilly" reported in late March "Without particularly looking" https://bioworld.com/articles/434094-sitryx-banks-60m-in-immunometabolism-drug-deal-with-lilly
Paul Peter Tak (a former SVP at GSK) also co-founded Sitryx. He also sits on the board of Kintai alongside Luke O Neill.
Paul Peter Tak (a former SVP at GSK) also co-founded Sitryx. He also sits on the board of Kintai alongside Luke O Neill.
The chairman of that "Kintai" board John Mendlein is also an executive partner at "Flagship Pioneering" (Paul Peter Tak joined this company in 2018). "Flagship Pioneering" is the company that founded "Moderna". This is a leading mRNA vaccine candidate in "Operation Warp Speed".
In fact "Flagship Pioneering" founded both "Kintai" https://flagshippioneering.com/companies/kintai-therapeutics and "Moderna" Luke O'Neill sits on the board of "Kintai" under chairman John Mendlein https://kintaitx.com/about/ who only withdrew from "Moderna" in early 2019 and may still advise https://businesswire.com/news/home/20190118005093/en/Dr.-John-Mendlein-Transition-Advisory-Role-Moderna.
Here he is shown lying, demonising the Swedish response which later turned out to be very successful and overstating the efficacy of lockdown ...